跳至主要内容
临床试验/NCT04923867
NCT04923867已完成不适用

A Multicenter, Retrospective, Post-Market Clinical Follow-Up Study to Evaluate the Performance and Safety of Suturable DuraGen™

Integra LifeSciences Corporation3 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2021年4月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
260
试验地点
3
主要终点
Patient Outcome

研究概览

简要总结

The primary goal of this study is to retrospectively collect data on the safety and efficacy of Suturable DuraGen™.

详细描述

This is a multicenter, non-randomized, non-interventional, retrospective Post-Market Clinical Follow-up (PMCF) study to evaluate the occurrence of post-operative cerebrospinal fluid (CSF) leaks within 30 days (and up to 90 days) after use of Suturable DuraGen™ for a supratentorial, infratentorial, or spinal procedure.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is between 18 and 80 years of age
  • Subject has undergone either a supratentorial, an infratentorial, or a spinal procedure with the use of Suturable DuraGen™ prior to trial initiation
  • Availability of post-operative assessment results.

排除标准

  • There are no exclusionary criteria for this study population

结局指标

主要结局

Patient Outcome

时间窗: post-up to 90 days

Occurrence of post-operative cerebrospinal fluid (CSF) leaks post-procedure

次要结局

  • Occurrence of Adverse Event(Between days 30-90)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Suturable DuraGen™ PMCF Study | 临床试验